Narcotic Addict Treatment Act
GPTKB entity
Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:administeredBy |
gptkb:Drug_Enforcement_Administration
|
| gptkbp:alsoKnownAs |
gptkb:NATA
|
| gptkbp:amendedBy |
gptkb:Controlled_Substances_Act
|
| gptkbp:appliesTo |
gptkb:physician
treatment programs |
| gptkbp:codifiedIn |
21 U.S.C. § 823(g)
|
| gptkbp:dateEnacted |
1974
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
Narcotic Addict Treatment Act
|
| gptkbp:partOf |
gptkb:Comprehensive_Drug_Abuse_Prevention_and_Control_Act_of_1970
|
| gptkbp:purpose |
to control and regulate the treatment of narcotic addiction with narcotic drugs
|
| gptkbp:regulates |
use of LAAM for opioid addiction treatment
use of methadone for opioid addiction treatment |
| gptkbp:requires |
special DEA registration for narcotic addiction treatment
registration of practitioners dispensing narcotic drugs for addiction treatment |
| gptkbp:bfsParent |
gptkb:DEA_Diversion_Investigators
|
| gptkbp:bfsLayer |
7
|